| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
Receptor (PPAR)EndocannabinoidImmunosuppressive agentsKidney (Chronic renal failure)FibrosisMacrophagesLXR| 1 | 2002 | The role of PPARs in inflammation and immunity. | 
| + | - | nl | J Leukoc Biol 71(3):388-400 (2002) |
| 2 | 2008 | The Role of PPARs in Cancer. |
| + | - | nl | PPAR Res 2008(-):102737 (2008) |
| 3 | 2008 | Peroxisome proliferator-activated receptors in diabetic nephropathy. |
| + | - | nl | PPAR Res 2008(-):879523 (2008) |
| 4 | 2007 | Cannabinoids: a new group of agonists of PPARs. |
| + | - | nl | PPAR Res 2007(-):23513 (2007) |
| 5 | 2001 | Peroxisome proliferator-activated receptors: from genes to physiology. |
| + | - | nl | Recent Prog Horm Res 56(-):239-63 (2001) |
| 6 | 2001 | Nonhypoglycemic effects of thiazolidinediones. |
| + | - | nl | Ann Intern Med 134(1):61-71 (2001) |
| 7 | 1993 | Peroxisome proliferator-activated receptor (PPAR): structure, mechanisms of activation and diverse functions. |
| + | - | nl | Cell Struct Funct 18(5):267-77 (1993) |
| 8 | 2007 | Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets. |
| + | - | nl | Circulation 115(4):518-33 (2007) |
| 9 | 2001 | PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth. |
| + | - | nl | J Biol Chem 276(41):37731-4 (2001) |
| 10 | 2006 | The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR). |
| + | - | nl | Toxicol Sci 90(2):269-95 (2006) |
| 11 | 1999 | PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function. |
| + | - | nl | Cell 99(3):239-42 (1999) |
| 12 | 2010 | Peroxisome proliferator-activated receptor translational research and clinical experience. |
| + | - | nl | Am J Clin Nutr 91(1):262S-266S (2010) Cheatham WW |
| 13 | 2011 | PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation. |
| + | - | nl | Biochim Biophys Acta 1812(8):1007-22 (2011) |
| 14 | 2007 | PPARs and molecular mechanisms of transrepression. | 
| + | - | nl | Biochim Biophys Acta 1771(8):926-35 (2007) |
| 15 | 2007 | Modulation of PPAR activity via phosphorylation. |
| + | - | nl | Biochim Biophys Acta 1771(8):952-60 (2007) |
| 16 | 2010 | PPAR modulation of kinase-linked receptor signaling in physiology and disease. |
| + | - | nl | Physiology (Bethesda) 25(3):176-85 (2010) |
| 17 | 2006 | Are peroxisome proliferator-activated receptors new therapeutic targets in diabetic and non-diabetic nephropathies? |
| + | - | nl | Nephrol Dial Transplant 21(10):2696-702 (2006) |
| 18 | 2010 | Control of macrophage activation and function by PPARs. |
| + | - | nl | Circ Res 106(10):1559-69 (2010) |
| 19 | 2006 | International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. |
| + | - | nl | Pharmacol Rev 58(4):726-41 (2006) |
| 20 | 2008 | Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors. |
| + | - | nl | Curr Opin Genet Dev 18(5):461-7 (2008) |
| 21 | 2009 | PPARs and the cardiovascular system. |
| + | - | nl | Antioxid Redox Signal 11(6):1415-52 (2009) |
